A study to assess role of Dupilumab in patients with idiopathic chronic eczematous eruption of aging (CEEA)
Latest Information Update: 27 Jul 2020
At a glance
- Drugs Dupilumab (Primary)
- Indications Eczema; Skin eruptions
- Focus Adverse reactions; Therapeutic Use
- 27 Jul 2020 New trial record
- 14 Jul 2020 Results published in the Journal of the American Academy of Dermatology